Summary & Overview
CPT 43881: Gastric Electrical Stimulation for Refractory Gastroparesis
CPT code 43881 represents placement of gastric electrical stimulation electrodes on the antrum to treat refractory nausea and vomiting from gastroparesis, a condition that can be a complication of diabetes. The code covers a targeted surgical implant procedure used when medical therapy has failed to control symptoms. Nationally, this code is relevant across inpatient and outpatient surgical settings and for specialty gastroenterology and surgical practices managing severe gastroparesis.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical indication and service setting for CPT code 43881, typical payer coverage considerations, common modifiers used with the service, and the operational contexts where the procedure is performed. The publication also summarizes benchmarking metrics and policy updates where available, and offers clinical context on gastroparesis and the role of gastric electrical stimulation.
This summary equips billing, coding, and revenue teams, as well as clinical managers, with the practical context needed to classify the service line, anticipate site-of-service implications, and align documentation with payer requirements. Data not available in the input are noted where applicable in the detailed sections.
Billing Code Overview
CPT code 43881 describes a surgical procedure in which the provider places electrodes on the antrum of the stomach to treat nausea and vomiting caused by gastroparesis that has not responded to drug therapy. The procedure targets gastric electrical stimulation for patients with impaired gastric emptying, including cases related to diabetic gastroparesis.
Service Type: Surgical implant / gastric electrical stimulation
Typical Site of Service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 42-year-old woman with long-standing type 1 diabetes presents with refractory nausea, vomiting, early satiety and weight loss despite optimized glycemic control and trials of prokinetic agents (metoclopramide, erythromycin) and antiemetics. Gastric emptying scintigraphy confirms delayed gastric emptying consistent with gastroparesis. After multidisciplinary evaluation by gastroenterology and surgery and failure of conservative and pharmacologic therapy, the patient is scheduled for laparoscopic implantation of a gastric electrical stimulator. The procedure involves intraoperative placement of electrodes on the gastric antrum, connection to a subcutaneous pulse generator, testing of lead function, and programming of stimulation parameters.
Typical workflow: preoperative evaluation and informed consent, pre-op anesthesia assessment, intraoperative laparoscopic placement of serosal leads on the gastric antrum with tunneling to a subcutaneous pocket for the pulse generator, intraoperative device testing, and postoperative programming and follow-up visits for symptom monitoring and parameter adjustments. Typical site of service: outpatient surgical center or hospital operating room. Service type: operative surgical implant procedure for treatment-resistant gastroparesis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier applies. |